Treatment of Restrictive Cardiomyopathy: Heart Failure Medications and Device Implantation
Restrictive cardiomyopathy requires a carefully structured approach. Management is tailored to the patient's symptoms, heart failure phenotype, and disease severity — combining pharmacologic therapy with device-based interventions where indicated.
First-Line Treatment Approach
The protocol involves administering heart failure medications in conjunction with device implantation — including the use of a ventricular assist device as a bridge-to-candidacy in select cases. The specific combination and sequencing are determined by the heart failure phenotype and clinical severity. The complete protocol specifies which interventions apply and under what conditions.
References
DOI: 10.1093/eurheartj/ehad194
The administration of heart failure medications and device implantation, including ventricular assist device as a bridge-to-candidacy is guided by symptoms and heart failure phenotype and severity, and is described in Section 6.10.2.
View source ↗